Literature DB >> 25142380

Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease.

Andrew S P Lim1, Brian A Ellison2, Joshua L Wang2, Lei Yu3, Julie A Schneider3, Aron S Buchman3, David A Bennett3, Clifford B Saper4.   

Abstract

Fragmented sleep is a common and troubling symptom in ageing and Alzheimer's disease; however, its neurobiological basis in many patients is unknown. In rodents, lesions of the hypothalamic ventrolateral preoptic nucleus cause fragmented sleep. We previously proposed that the intermediate nucleus in the human hypothalamus, which has a similar location and neurotransmitter profile, is the homologue of the ventrolateral preoptic nucleus, but physiological data in humans were lacking. We hypothesized that if the intermediate nucleus is important for human sleep, then intermediate nucleus cell loss may contribute to fragmentation and loss of sleep in ageing and Alzheimer's disease. We studied 45 older adults (mean age at death 89.2 years; 71% female; 12 with Alzheimer's disease) from the Rush Memory and Aging Project, a community-based study of ageing and dementia, who had at least 1 week of wrist actigraphy proximate to death. Upon death a median of 15.5 months later, we used immunohistochemistry and stereology to quantify the number of galanin-immunoreactive intermediate nucleus neurons in each individual, and related this to ante-mortem sleep fragmentation. Individuals with Alzheimer's disease had fewer galaninergic intermediate nucleus neurons than those without (estimate -2872, standard error = 829, P = 0.001). Individuals with more galanin-immunoreactive intermediate nucleus neurons had less fragmented sleep, after adjusting for age and sex, and this association was strongest in those for whom the lag between actigraphy and death was <1 year (estimate -0.0013, standard error = 0.0005, P = 0.023). This association did not differ between individuals with and without Alzheimer's disease, and similar associations were not seen for two other cell populations near the intermediate nucleus. These data are consistent with the intermediate nucleus being the human homologue of the ventrolateral preoptic nucleus. Moreover, they demonstrate that a paucity of galanin-immunoreactive intermediate nucleus neurons is accompanied by sleep fragmentation in older adults with and without Alzheimer's disease.
© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; human; hypothalamus; intermediate nucleus; sleep

Mesh:

Substances:

Year:  2014        PMID: 25142380      PMCID: PMC4163039          DOI: 10.1093/brain/awu222

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  64 in total

Review 1.  A guide to the perplexed on the specificity of antibodies.

Authors:  Clifford B Saper
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

2.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

3.  Afferents to the ventrolateral preoptic nucleus.

Authors:  Thomas C Chou; Alvhild A Bjorkum; Stephanie E Gaus; Jun Lu; Thomas E Scammell; Clifford B Saper
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Activation of ventrolateral preoptic neurons during sleep.

Authors:  J E Sherin; P J Shiromani; R W McCarley; C B Saper
Journal:  Science       Date:  1996-01-12       Impact factor: 47.728

5.  Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals.

Authors:  Andrew S P Lim; Lei Yu; Madalena D Costa; Sue E Leurgans; Aron S Buchman; David A Bennett; Clifford B Saper
Journal:  Sleep       Date:  2012-05-01       Impact factor: 5.849

Review 6.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

7.  Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats.

Authors:  R Szymusiak; N Alam; T L Steininger; D McGinty
Journal:  Brain Res       Date:  1998-08-24       Impact factor: 3.252

8.  Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently.

Authors:  J A van de Nes; W Kamphorst; R Ravid; D F Swaab
Journal:  Acta Neuropathol       Date:  1998-08       Impact factor: 17.088

9.  Sleep-disordered breathing in community-dwelling elderly.

Authors:  S Ancoli-Israel; D F Kripke; M R Klauber; W J Mason; R Fell; O Kaplan
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

10.  A sexually dimorphic nucleus in the human brain.

Authors:  D F Swaab; E Fliers
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

View more
  56 in total

1.  Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease.

Authors:  Shahmir Sohail; Lei Yu; Julie A Schneider; David A Bennett; Aron S Buchman; Andrew S P Lim
Journal:  Mov Disord       Date:  2017-10-30       Impact factor: 10.338

2.  Accumulated deep sleep is a powerful predictor of LH pulse onset in pubertal children.

Authors:  N D Shaw; J P Butler; S Nemati; T Kangarloo; M Ghassemi; A Malhotra; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2014-12-09       Impact factor: 5.958

Review 3.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 4.  Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?

Authors:  Bryce A Mander; Joseph R Winer; William J Jagust; Matthew P Walker
Journal:  Trends Neurosci       Date:  2016-06-17       Impact factor: 13.837

5.  An assembly of galanin-galanin receptor signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Chinmayi Raj; Deepshika Pullimamidi; Jayshree Advani; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

6.  Sex- and Age-dependent Differences in Sleep-wake Characteristics of Fisher-344 Rats.

Authors:  Andrey Kostin; Md Aftab Alam; Jerome M Siegel; Dennis McGinty; Md Noor Alam
Journal:  Neuroscience       Date:  2019-12-14       Impact factor: 3.590

Review 7.  Sleep Disturbance, Cognitive Decline, and Dementia: A Review.

Authors:  Alexandra M V Wennberg; Mark N Wu; Paul B Rosenberg; Adam P Spira
Journal:  Semin Neurol       Date:  2017-08-24       Impact factor: 3.420

8.  Disrupted Sleep in Narcolepsy: Exploring the Integrity of Galanin Neurons in the Ventrolateral Preoptic Area.

Authors:  Yury V Gavrilov; Brian A Ellison; Mihoko Yamamoto; Hasini Reddy; Johannes Haybaeck; Emmanuel Mignot; Christian R Baumann; Thomas E Scammell; Philipp O Valko
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

9.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

10.  Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.

Authors:  Andrew W Varga; Margaret E Wohlleber; Sandra Giménez; Sergio Romero; Joan F Alonso; Emma L Ducca; Korey Kam; Clifton Lewis; Emily B Tanzi; Samuel Tweardy; Akifumi Kishi; Ankit Parekh; Esther Fischer; Tyler Gumb; Daniel Alcolea; Juan Fortea; Alberto Lleó; Kaj Blennow; Henrik Zetterberg; Lisa Mosconi; Lidia Glodzik; Elizabeth Pirraglia; Omar E Burschtin; Mony J de Leon; David M Rapoport; Shou-En Lu; Indu Ayappa; Ricardo S Osorio
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.